Cite
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma
MLA
Samantha E. Jacobs, et al. “Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma.” Clinical Lymphoma Myeloma and Leukemia, vol. 21, May 2021, pp. e470–76. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....10bde31a099d0987628fd869af112e47&authtype=sso&custid=ns315887.
APA
Samantha E. Jacobs, Joshua Richter, Shambavi Richard, Samir Parekh, Katleen S Lozada, Deepu Madduri, Guido Lancman, Hearn Jay Cho, Sundar Jagannath, Ajai Chari, Nida Athar, & John Doucette. (2021). Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia, 21, e470–e476.
Chicago
Samantha E. Jacobs, Joshua Richter, Shambavi Richard, Samir Parekh, Katleen S Lozada, Deepu Madduri, Guido Lancman, et al. 2021. “Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma.” Clinical Lymphoma Myeloma and Leukemia 21 (May): e470–76. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....10bde31a099d0987628fd869af112e47&authtype=sso&custid=ns315887.